Orthofix Medical Market Capitalization

OFIX Stock

USD 12.35 0.20 1.65%

Orthofix Medical's latest Market Capitalization figure appears below alongside the formula and what it measures. Understanding the formula helps clarify what this metric measures. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Market Cap

Shares Outstanding

X

Share Price

487.75 M

In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size. Orthofix Medical's Market Capitalization reflects values from the latest available filings. All figures reflect reported accounting data.

Latest Orthofix Medical Market Cap Growth Pattern

Market Cap

10 Years Trend

High Variability

Compare to Others All Financials

Market Cap

Timeline

Market Cap Trend Statistics

Orthofix Medical reports Market Cap with a coefficient of variation of 35.2% over 15 periods, reflecting elevated dispersion relative to the mean. R-squared at 0.00 is consistent with no statistically meaningful linear trend.

	Arithmetic Mean	629,728,742
	Geometric Mean	573,408,479
	Coefficient Of Variation	35.21
	Mean Deviation	165,492,322
	Median	612,180,536
	Standard Deviation	221,697,967
	Sample Variance	49150T
	Range	894.8M
	R-Value	0.06
	Mean Square Error	52227.2T
	R-Squared	0.0038
	Significance	0.81
	Slope	2,707,660
	Total Sum of Squares	786399.8T

Orthofix Medical Market Cap History

The historical record covers 15 periods of Orthofix Medical's Market Cap from 2011 (641.9 M) to 2026 (431.9 M).

	2026	431.9 M
	2025	544.2 M
	2024	604.6 M
	2022	495.1 M
	2021	612.2 M
	2020	828.1 M
	2019	873 M
	2018	970.8 M
	2017	991 M
	2016	656.5 M
	2015	737 M
	2014	554.9 M
	2013	426.7 M
	2012	746.4 M
	2011	641.9 M

Correlation of Market Cap With Other Accounts

Below are pairwise correlations of Orthofix Medical's Market Cap with other financial line items. Coefficients range from −1 (perfect inverse) to +1 (perfect co-movement). These values describe historical association and do not imply causation.

Related Fundamentals

	Last Reported	End Of Year Estimate
Selling And Marketing Expenses	443.6 M	465.8 M
Price To Sales Ratio	0.74	0.70
PTB Ratio	1.34	2.35
Days Sales Outstanding	60.25	98.89
Book Value Per Share	11.28	11.18

Market Capitalization Driver Correlations

The correlation data quantifies how Market Capitalization at Orthofix Medical relates to other financial line items. These relationships describe association across reporting periods, not causation.

Competition

Market Cap Over Time

Orthofix Long Term Debt To Capitalization

Long Term Debt To Capitalization

0.15

Long Term Debt To Capitalization stood at 0.29 as of December 31, 2025.

Fundamental Drivers Relationships

Market Cap stood at 431.88 Million as of December 31, 2025. Related reported indicator: Selling And Marketing Expenses at 465.78 Million as of December 31, 2025.

Market Capitalization Peer Comparison

Comparing Orthofix Medical's Market Capitalization to that of its competitors is a reliable method for assessing relative value. Comparing Orthofix Medical's Market Capitalization to peer stocks determines whether it trades at a premium or discount. Tracking Orthofix Medical's Market Capitalization rank within the peer group over time reveals shifts in competitive dynamics. The Market Capitalization peer framework provides a practical lens for evaluating Orthofix Medical's relative standing.

Orthofix Medical is currently under evaluation in market capitalization among leading competitors.

Important Fundamentals

	Return On Equity	-0.19
	Return On Asset	-0.0491
	Profit Margin	-0.11
	Operating Margin	-0.0127
	Current Valuation	584.16 M
	Shares Outstanding	40.14 M
	Shares Owned By Insiders	2.83 %
	Shares Owned By Institutions	90.04 %
	Number Of Shares Shorted	1.2 M
	Price To Earnings	338.00 X
	Price To Book	1.08 X
	Price To Sales	0.59 X
	Revenue	822.31 M
	Gross Profit	566.02 M
	EBITDA	-22.35 M
	Net Income	-92.19 M
	Cash And Equivalents	59.54 M
	Cash Per Share	2.98 X
	Total Debt	229.26 M
	Debt To Equity	0.08 %
	Current Ratio	3.15 X
	Book Value Per Share	11.30 X
	Cash Flow From Operations	33.35 M
	Short Ratio	4.28 X
	Earnings Per Share	-2.33 X
	Price To Earnings To Growth	8.10 X
	Target Price	17.25
	Number Of Employees	1.6 K
	Trailing Beta	0.82
	Market Capitalization	487.75 M
	Total Asset	850.65 M
	Retained Earnings	-368.33 M
	Working Capital	246.37 M
	Current Asset	147.87 M
	Current Liabilities	52.94 M
	Net Asset	850.65 M

Financial Metrics, Fundamentals & Methodology

The financial architecture of Orthofix Medical shows how effectively the business turns scale into retained value. Operating margins help show whether the business still holds structural pricing or cost advantages. Latest reported fundamentals for Orthofix Medical include revenue of 822.31 M, EPS loss of 2.33, negative operating margin of 1.27%, current ratio of 3.15 as of the latest reporting period.

Orthofix Medical inputs come from periodic company reporting and market reference feeds and are mapped into a consistent reporting framework. Where analyst coverage exists, consensus estimates are factored in. Reported income, balance-sheet, and cash-flow fields adhere to GAAP or IFRS presentation rules.

Editorial review and methodology oversight provided by: Michael Smolkin, Member of Macroaxis Board of Directors

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable
Common Stock Shares Outstanding		0.75	0.81	0.84	0.68	0.18	0.7	-0.91	0.97
Total Assets	0.75		0.66	0.85	0.92	0.55	0.6	-0.54	0.76
Short Long Term Debt Total	0.81	0.66		0.9	0.4	-0.06	0.95	-0.79	0.77
Total Current Liabilities	0.84	0.85	0.9		0.67	0.24	0.8	-0.69	0.83
Total Stockholder Equity	0.68	0.92	0.4	0.67		0.67	0.34	-0.38	0.7
Property Plant And Equipment Net	0.18	0.55	-0.06	0.24	0.67		-0.03	0.05	0.2
Net Debt	0.7	0.6	0.95	0.8	0.34	-0.03		-0.7	0.69
Retained Earnings	-0.91	-0.54	-0.79	-0.69	-0.38	0.05	-0.7		-0.88
Accounts Payable	0.97	0.76	0.77	0.83	0.7	0.2	0.69	-0.88

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share
Price To Sales Ratio		0.83	0.33	-0.45	0.34	-0.06	0.83	0.98	0.31
Ptb Ratio	0.83		0.28	-0.32	0.51	0.0	1.0	0.88	0.52
Days Sales Outstanding	0.33	0.28		-0.44	0.1	0.19	0.28	0.34	-0.02
Book Value Per Share	-0.45	-0.32	-0.44		-0.02	0.29	-0.32	-0.35	0.12
Free Cash Flow Yield	0.34	0.51	0.1	-0.02		0.01	0.51	0.41	0.92
Capex To Depreciation	-0.06	0.0	0.19	0.29	0.01		0.0	-0.02	-0.03
Pb Ratio	0.83	1.0	0.28	-0.32	0.51	0.0		0.88	0.52
Ev To Sales	0.98	0.88	0.34	-0.35	0.41	-0.02	0.88		0.41
Free Cash Flow Per Share	0.31	0.52	-0.02	0.12	0.92	-0.03	0.52	0.41